MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...

It will also measure key pharmacodynamic markers such as the depth and speed of IgG minimisation and the ... Seismic Therapeutic plans to test the drug's efficacy as a chronic and acute treatment ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Then, binding tests were performed by functionalizing the neck ... thus paving the way to the possibility to detect the IgG in an ultra-wide concentration range over four orders of magnitude via a ...